|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Darling G: The role of lymphadenectomy in
esophageal cancer. J Surg Oncol. 99:189–193. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Kranzfelder M, Schuster T, Geinitz H,
Friess H and Buchler P: Meta-analysis of neoadjuvant treatment
modalities and definitive non-surgical therapy for oesophageal
squamous cell cancer. Br J Surg. 98:768–783. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Chiu PW, Chan AC, Leung SF, et al:
Multicenter prospective randomized trial comparing standard
esophagectomy with chemoradiotherapy for treatment of squamous
esophageal cancer: early results from the chinese university
research group for esophageal cancer (CURE). J Gastrointest Surg.
9:794–802. 2005. View Article : Google Scholar
|
|
5.
|
Xu XH, Peng XH, Yu P, Xu XY, Cai EH, Guo P
and Li K: Neoadjuvant chemotherapy for resectable esophageal
carcinoma: a meta-analysis of randomized clinical trials. Asian Pac
J Cancer Prev. 13:103–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Hynes RO: Integrins: versatility,
modulation, and signaling in cell adhesion. Cell. 69:11–25. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Giancotti FG and Tarone G: Positional
control of cell fate through joint integrin/receptor protein kinase
signaling. Annu Rev Cell Dev Biol. 19:173–206. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Avraamides CJ, Garmy-Susini B and Varner
JA: Integrins in angio genesis and lymphangiogenesis. Nat Rev
Cancer. 8:604–617. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Mizejewski GJ: Role of integrins in
cancer: survey of expression patterns. Proc Soc Exp Biol Med.
222:124–138. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Hwang R and Varner J: The role of
integrins in tumor angiogenesis. Hematol Oncol Clin North Am.
18:991–1006. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Friedrichs K, Ruiz P, Franke F, Gille I,
Terpe HJ and Imhof BA: High expression level of alpha 6 integrin in
human breast carcinoma is correlated with reduced survival. Cancer
Res. 55:901–906. 1995.PubMed/NCBI
|
|
12.
|
Mercurio AM and Rabinovitz I: Towards a
mechanistic understanding of tumor invasion - lessons from the
alpha6beta 4 integrin. Semin Cancer Biol. 11:129–141. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Mukhopadhyay R, Theriault RL and Price JE:
Increased levels of alpha6 integrins are associated with the
metastatic phenotype of human breast cancer cells. Clin Exp
Metastasis. 17:325–332. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Wewer UM, Shaw LM, Albrechtsen R and
Mercurio AM: The integrin alpha 6 beta 1 promotes the survival of
metastatic human breast carcinoma cells in mice. Am J Pathol.
151:1191–1198. 1997.PubMed/NCBI
|
|
15.
|
Hemler ME, Crouse C and Sonnenberg A:
Association of the VLA alpha 6 subunit with a novel protein. A
possible alternative to the common VLA beta 1 subunit on certain
cell lines. J Biol Chem. 264:6529–6535. 1989.PubMed/NCBI
|
|
16.
|
Hu YC, Lam KY, Law S, Wong J and
Srivastava G: Profiling of differentially expressed cancer-related
genes in esophageal squamous cell carcinoma (ESCC) using human
cancer cDNA arrays: overexpression of oncogene MET correlates with
tumor differentiation in ESCC. Clin Cancer Res. 7:3519–3525.
2001.
|
|
17.
|
Kwon YJ, Lee SJ, Koh JS, Kim SH, Kim YJ
and Park JH: Expression patterns of aurora kinase B, heat shock
protein 47, and periostin in esophageal squamous cell carcinoma.
Oncol Res. 18:141–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Lathia JD, Gallagher J, Heddleston JM, et
al: Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem
Cell. 6:421–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Tew WP, Kelsen DP and Ilson DH: Targeted
therapies for esophageal cancer. Oncologist. 10:590–601. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Vanhoefer U, Tewes M, Rojo F, et al: Phase
I study of the humanized antiepidermal growth factor receptor
monoclonal antibody EMD72000 in patients with advanced solid tumors
that express the epidermal growth factor receptor. J Clin Oncol.
22:175–184. 2004. View Article : Google Scholar
|
|
21.
|
Capdevila J, Elez E, Macarulla T, Ramos
FJ, Ruiz-Echarri M and Tabernero J: Anti-epidermal growth factor
receptor monoclonal antibodies in cancer treatment. Cancer Treat
Rev. 35:354–363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Cruz-Monserrate Z and O’Connor KL:
Integrin alpha 6 beta 4 promotes migration, invasion through Tiam1
upregulation, and subsequent rac activation. Neoplasia. 10:408–417.
2008.PubMed/NCBI
|
|
23.
|
Yang XH, Richardson AL, Torres-Arzayus MI,
et al: CD151 accelerates breast cancer by regulating alpha 6
integrin function, signaling, and molecular organization. Cancer
Res. 68:3204–3213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Chung J and Mercurio AM: Contributions of
the alpha6 integrins to breast carcinoma survival and progression.
Mol Cells. 17:203–209. 2004.PubMed/NCBI
|
|
25.
|
Cariati M, Naderi A, Brown JP, Smalley MJ,
Pinder SE, Caldas C and Purushotham AD: Alpha-6 integrin is
necessary for the tumourigenicity of a stem cell-like subpopulation
within the MCF7 breast cancer cell line. Int J Cancer. 122:298–304.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Su JM, Gui L, Zhou YP and Zha XL:
Expression of focal adhesion kinase and alpha5 and beta1 integrins
in carcinomas and its clinical significance. World J Gastroenterol.
8:613–618. 2002.PubMed/NCBI
|
|
27.
|
Varner JA, Emerson DA and Juliano RL:
Integrin alpha 5 beta 1 expression negatively regulates cell
growth: reversal by attachment to fibronectin. Mol Biol Cell.
6:725–740. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Beaulieu JF: Integrin alpha6beta4 in
colorectal cancer. World J Gastrointest Pathophysiol. 1:3–11.
2010.PubMed/NCBI
|
|
29.
|
Noh TW, Soung YH, Kim HI, Gil HJ, Kim JM,
Lee EJ and Chung J: Effect of {beta}4 integrin knockdown by RNA
interference in anaplastic thyroid carcinoma. Anticancer Res.
30:4485–4492. 2010.
|
|
30.
|
Bon G, Folgiero V, Di Carlo S, Sacchi A
and Falcioni R: Involvement of alpha6beta4 integrin in the
mechanisms that regulate breast cancer progression. Breast Cancer
Res. 9:2032007. View
Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Lu X, Lu D, Scully M and Kakkar V: The
role of integrins in cancer and the development of anti-integrin
therapeutic agents for cancer therapy. Perspect Medicin Chem.
2:57–73. 2008.PubMed/NCBI
|
